Influence of microenvironments on microcirculation patterns and tumor invasion-related protein expression in melanoma

Oncology Reports

Volumn 21, Issue 4, 2009, Pages 917-923

  Chen, Luxia ^a   Sun, Baocun ^a,b   Zhang, Shiwu ^b   Zhao, Xiulan ^a   He, Yanjin ^a   Zhao, Shaozhen ^a   Lin, Tingting ^a   Li, Xiaorong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

Epithelial cell kinase; Matrix metalloproteinase; Melanoma; Microenvironment; Vasculogenic mimicry

Indexed keywords

EPHRIN RECEPTOR A2; GELATINASE A; GELATINASE B; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CANCER CELL; CANCER GRAFT; CANCER INVASION; CANCER TISSUE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INGUINAL REGION; LUNG METASTASIS; MALE; MELANOMA; MELANOMA B16; METASTASIS; MICROCIRCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION; ANIMAL; C57BL MOUSE; GENETICS; PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; FEMALE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELANOMA; MICE; MICE, INBRED C57BL; MICROCIRCULATION; NEOPLASM INVASIVENESS; RECEPTOR, EPHA2; RNA, MESSENGER;

EID: 67449103791     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000304     Document Type: Article

References (37)

1. Maniotis AJ, Folberg R, Hess A, Seftor A, Gardner LM, Trent JM, Meltzer PS and Hendrix MJ: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155: 739-752, 1999.
2. Bissell MJ: Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch: a rose by any other name? Am J Pathol 155: 675-679, 1999.
3. Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE, Seftor RE and Hendrix MJ: Molecular determinants of ovarian cancer plasticity. Am J Pathol 158: 1279-1288, 2001.
4. Folberg R, Hendrix MJ and Maniotis AJ: Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156: 361-381, 2000.
5. Seftor EA, Meltzer PS, Kirschmann DA, Maniotis AJ, Trent JM, Folberg R and Hendrix MJ: Molecular determinants of human melanoma invasion and metastasis. Clin Exp Metastasis 19: 233-246, 2002.
6. Rofstad EK, Mathiesen B and Galappathi K: Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor. Cancer Res 64: 13-18, 2004.
7. Giatromanolaki A, Koukourakis MI, Sowter HM, Sivridis E, Gibson S, Gatter KC and Harris AL: BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer. Clin Cancer Res 10: 5566-5571, 2004.
8. Folgueras AR, Pendas AM, Sanchez LM and Lopez-Otin C: Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48: 411-424, 2004.
9. Hess AR, Seftor EA, Seftor RE and Hendrix MJ: Phosphoinositide 3-kinase regulates membrane type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res 63: 4757-4762, 2003.
10. Seftor EA, Meltzer PS, Kirschmann DA, Margaryan NV, Seftor RE and Hendrix MJ: The epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment. J Cell Mol Med 10: 174-196, 2006.
11. Scala S, Ottaiano A, Ascierto PA, Cavalli M, Simeone E, Giuliano P, Napolitano M, Franco R, Botti G and Castello G: Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res 11: 1835-1841, 2005.
12. Laurenzi L, Natoli S, Di Filippo F, Calamaro A, Centulio F, Anza M, Cavaliere F, Marcelli ME, Garinei R and Arcuri E: Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha. J Exp Clin Cancer Res 23: 225-231, 2004.
13. Maniotis AJ: Control of melanoma morphogenesis, endothelial survival, and perfusion by extracellular matrix. Lab Invest 82: 1031-1043, 2002.
14. Folberg R and Maniotis AJ: Vasculogenic mimicry. APMIS 112: 508-525, 2004.
15. Lee YJ, Nagai N, Siar CH, Nakano K, Nagatsuka H, Tsujigiwa H, Roan CH and Gunduz M: Angioarchitecture of primary oral malignant melanomas. J Histochem Cytochem 50: 1555-1562, 2002.
16. Dai J, Keller J, Zhang J, Lu Y, Yao Z and Keller ET: Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. Cancer Res 65: 8274-8285, 2005.
17. Miyoshi A, Kitajima Y, Ide T, Ohtaka K, Nagasawa H, Uto Y, Hori H and Miyazaki K: Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1α-independent manner. Int J Oncol 29: 1533-1539, 2006.
18. Nguyen QD, Wever O, Bruyneel E, Hendrix A, Xie WZ, Lombet A, Leibl M, Mareel M, Gieseler F, Bracke M and Gespach C: Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho-Rho kinase axis and tumor microenvironment. Oncogene 24: 8240-8251, 2005.
19. Dong D, Baumeister P, Swenson S, Costa F, Markland F, Stiles C, Patterson JB, Bates SE and Lee AS: Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment. Cancer Res 65: 5785-5791, 2005.
20. Yagmurdur MC, Basaran O, Ozdemir H, Gur G, Tran M, Karakayali H and Haberal M: The impact of transient elevation of intra-abdominal pressure on liver regeneration in the rat. J Invest Surg 17: 315-322, 2004.
21. Pietras K, Ostman A, Sjoquist M, Buchdunger E, Reed RK, Heldin CH and Rubin K: Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res 61: 2929-2934, 2001.
22. Sun BC, Zhang SW, Zhao XL and Hao XS: Study on vasculogenic mimicry in malignant melanoma. Zhonghua Bing Li Xue Za Zhi 32: 539-543, 2003.
23. Gross J, Fuchs J, Machulik A, Jahnke V, Kietzmann T and Bockmuhl U: Apoptosis, necrosis and hypoxia inducible factor-1 in human head and neck squamous cell carcinoma cultures. Int J Oncol 27: 807-814, 2005.
24. Weinmann M, Jendrossek V, Guner D, Goecke B and Belka C: Cyclic exposure to hypoxia and reoxygenation selects for tumor cells with defects in mitochondrial apoptotic pathways. FASEB J 18: 1906-1908, 2004.
25. Seta KA and Millhorn DE: Functional genomics approach to hypoxia signaling. J Appl Physiol 96: 765-773, 2004.
26. Seftor EA, Meltzer PS, Schatteman GC, Gruman LM, Hess AR, Kirschmann DA, Seftor RE and Hendrix MJ: Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry. Crit Rev Oncol Hematol 44: 17-27, 2002.
27. Sun B, Zhang D, Zhang S, Zhang W, Guo H and Zhao X: Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett 249: 188-197, 2007.
28. Sun LC, Luo J, Mackey LV, Fuselier JA and Coy DH: A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. Cancer Lett 246: 157-166, 2007.
29. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG and Lisanti MP: Caveolin-1 gene disruption promotes mammary tumori-genesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 279: 51630-51646, 2004.
30. Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, Hammond EH, Devi SN, Kaur B and Van Meir EG: Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 64: 920-927, 2004.
31. Zelinski DP, Zantek ND, Stewart J, Irizarry A and Kinch MS: EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res 61: 2301-2306, 2001.
32. Brantley DM, Cheng N, Thompson EJ, et al: Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene 21: 7011-7026, 2002.
33. Ogawa K, Pasqualini R, Lindberg RA, Kain R, Freeman AL and Pasquale EB: The ephrin-A1 ligand and its receptor EphA2, are expressed during tumor neovascularization. Oncogene 19: 6043-6052, 2000.
34. Hess AR, Seftor EA and Gardner LM: Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). Cancer Res 61: 3250-3255, 2001.
35. Seftor RE, Seftor EA and Koshikawa N: Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 61: 6322-6327, 2001.
36. Hendrix MJ, Seftor EA, Hess AR and Seftor RE: Vasculogenic mimicry and tumor-cell plasticity: lessons from melanoma. Nat Rev Cancer 3: 411-421, 2003.
37. Hess AR, Seftor EA, Gruman LM, Kinch MS, Seftor RE and Hendrix MJ: VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway. Implications for vasculogenic mimicry. Cancer Biol Ther 5: 228-233, 2006.